VRTX icon

Vertex Pharmaceuticals
VRTX

Overview Fund Activity

695 hedge funds and large institutions have $46.6B invested in Vertex Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 253 increasing their positions, 247 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
695
Holders Change
+7
Holders Change %
+1.02%
% of All Funds
15.91%
Holding in Top 10
16
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.37%
New
72
Increased
253
Reduced
247
Closed
58
Calls
$403M
Puts
$352M
Net Calls
+$50.8M
Net Calls Change
+$62.6M

Top Buyers

1
Capital International Investors
Capital International Investors
California
+$554M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$512M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$330M
4
Jennison Associates
Jennison Associates
New York
+$220M
5
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$135M

Top Sellers

1
Capital World Investors
Capital World Investors
California
-$635M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$207M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$155M
4
Goldman Sachs
Goldman Sachs
New York
-$144M
5
Citadel Advisors
Citadel Advisors
Florida
-$134M
Name Holding Trade Value Shares
Change 		Shares
Change %
WT
751
Washington Trust
Rhode Island
– -$2K -13 Closed
DBT
752
Dubuque Bank & Trust
Iowa
– -$1K -7 Closed
TG
753
TLP Group
Illinois
– -$1K -5 Closed
27 28 29 30
31